We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+11.07%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$48.8B
AUM Growth
+$7.31B
Cap. Flow
+$2.97B
Cap. Flow %
6.1%
Top 10 Hldgs %
18.45%
Holding
760
New
71
Increased
309
Reduced
252
Closed
53

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$305M
2
CVS icon
CVS Health
CVS
+$190M
3
NVS icon
Novartis
NVS
+$175M
4
AVGO icon
Broadcom
AVGO
+$154M
5
WDC icon
Western Digital
WDC
+$144M

Sector Composition

Rank Sector Weight
1 Financials 24.38%
2 Healthcare 15.25%
3 Technology 13.09%
4 Industrials 10.62%
5 Energy 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICFI icon
401
ICF International
ICFI
$1.44B
$9.79M 0.02%
282,209
-191,800
-40% -$6.6M
SXI icon
402
Standex International
SXI
$3.68B
$9.79M 0.02%
155,719
+77,759
+100% +$4.71M
DMC
403
Del Monte Corp
DMC
$1.35B
$9.76M 0.02%
344,988
-5,707
-2% -$161K
LXP icon
404
LXP Industrial Trust
LXP
$3.53B
$9.7M 0.02%
189,964
+7,600
+4% +$414K
NLY icon
405
Annaly Capital Management
NLY
$16.9B
$9.66M 0.02%
+242,175
New +$10.5M
VRE
406
DELISTED
Veris Residential
VRE
$9.64M 0.02%
448,830
+17,840
+4% +$374K
USPH icon
407
US Physical Therapy
USPH
$1.14B
$9.59M 0.02%
271,864
-2,590
-0.9% -$84.8K
BWXT icon
408
BWX Technologies
BWXT
$16B
$9.52M 0.02%
389,226
-339,795
-47% -$7.96M
FUR
409
DELISTED
WINTHROP REALTY TRUST SHS BENE INT (NEW)
FUR
$9.5M 0.02%
859,860
+451,320
+110% +$5.11M
PNY
410
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$9.42M 0.02%
284,195
+11,250
+4% +$372K
SBY
411
DELISTED
Silver Bay Realty Trust Corp.
SBY
$9.41M 0.02%
588,749
-9,810
-2% -$155K
GE icon
412
GE Aerospace
GE
$367B
$9.13M 0.02%
67,970
FMBI
413
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$9.06M 0.02%
516,975
+20,260
+4% +$342K
TDC icon
414
Teradata
TDC
$2.68B
$8.98M 0.02%
+197,510
New +$8.95M
SINA
415
DELISTED
Sina Corp
SINA
$8.96M 0.02%
106,288
+29,114
+38% +$2.38M
MMM icon
416
3M
MMM
$89B
$8.85M 0.02%
75,472
+6,745
+10% +$718K
FMS icon
417
Fresenius Medical Care
FMS
$13.2B
$8.76M 0.02%
246,317
+26,877
+12% +$901K
GM icon
418
General Motors
GM
$74.7B
$8.72M 0.02%
+213,443
New +$8.06M
RTX icon
419
RTX Corp
RTX
$287B
$8.63M 0.02%
120,449
+2,383
+2% +$162K
GTI
420
DELISTED
GRAFTECH INTERNATIONAL LTD
GTI
$8.6M 0.02%
766,135
-71,070
-8% -$725K
MX icon
421
Magnachip Semiconductor
MX
$128M
$8.47M 0.02%
434,521
+3,021
+0.7% +$60.9K
HCOM
422
DELISTED
Hawaiian Telcom Holdco, Inc
HCOM
$8.35M 0.02%
284,214
CDZI icon
423
Cadiz
CDZI
$266M
$8.31M 0.02%
1,194,505
+86,280
+8% +$491K
DSX icon
424
Diana Shipping
DSX
$280M
$8.31M 0.02%
894,246
-29,276
-3% -$244K
FCX icon
425
Freeport-McMoran
FCX
$90B
$8.18M 0.02%
216,755

Similar funds

Boston Partners's Q4 2013 Portfolio in Review

As of Q4 2013, Boston Partners held 760 positions worth $48.8B, up 18% from $41.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners deployed $2.97B of net new capital in Q4 2013, opening 71 new positions and adding to 309 existing holdings. Its largest new stake was Novartis: 2,524,138 shares worth $182M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Halliburton, an estimated $260M trimmed.

  • Boston Partners's largest Q4 2013 buy was Novartis: 2,524,138 shares worth $182M.
  • Boston Partners added most to ExxonMobil in Q4 2013, an estimated $305M increase.
  • Boston Partners's biggest Q4 2013 reduction was Halliburton, cutting an estimated $260M.
  • Boston Partners fully exited NVIDIA in Q4 2013, selling an estimated $131M.
  • Boston Partners's ten largest holdings make up 18% of its $48.8B portfolio in Q4 2013.
  • Boston Partners opened 71 new positions and closed 53 in Q4 2013.
  • Boston Partners's portfolio value rose 18% quarter-over-quarter to $48.8B.

Based on Boston Partners's 13F filing for Q4 2013, filed 6 Feb 2014.